Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(559/week)
Manufacturing
(388/week)
Energy
(305/week)
Technology
(408/week)
Other Energy
(276/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Multiple myeloma
Dec 11, 2017
PharmaMar Presents Positive Results of the Pivotal Phase III Trial with Plitidepsin in Multiple Myeloma During the ASH Meeting
Dec 11, 2017
People Aged 75 Years and Older Are Underrepresented in Blood Cancer Clinical Trials
Dec 11, 2017
New Data for DARZALEX® (daratumumab) Presented at ASH 2017 Showed Feasibility of Subcutaneous Use and Promise of DARZALEX as a Treatment for Smoldering Multiple Myeloma
Dec 10, 2017
CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma
Dec 05, 2017
SkylineDx Poster Presentations at ASH Meeting Further Validate Use of MMprofiler(TM) with SKY92 in Multiple Myeloma
Dec 01, 2017
I-Mab Biopharma Partners with MorphoSys on Cancer Investigational Medicine
Nov 29, 2017
Lenalidomide Market to Grow on Account of Rising Usage in Treatment of Anemia & Multiple Myeloma Diseases till 2021: Million Insights
Nov 21, 2017
Janssen Submits Application to U.S. FDA to Expand Indication for DARZALEX® (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma who are Transplant Ineligible
Nov 13, 2017
SKY92 Gene Signature Facilitates Cost-effective, Risk-stratified Treatment of Multiple Myeloma
Nov 03, 2017
Global CAR T-cell Therapy for Multiple Myeloma Pipeline Analysis Report 2017
Oct 23, 2017
Phase 3 A.R.R.O.W. Study Of Once-Weekly KYPROLIS® (Carfilzomib) Regimen Meets Primary Endpoint Of Progression-Free Survival In Relapsed And Refractory Multiple Myeloma Patients
Oct 11, 2017
SkylineDx Announces Prognostic Tool to be Used as Part of Major New Myeloma Clinical Trial
Sep 14, 2017
SELLAS' Galinpepimut-S Induces Specific, Robust and Durable Immune Responses in Patients With High-Risk Multiple Myeloma - Correlated With Clinical Benefit
Aug 31, 2017
Multiple Myeloma Patients and Supporters Embark on Cross-Country Journey to Raise Awareness and Accelerate Cancer Research
Aug 30, 2017
Long-Term Analysis Of Phase 3 Head-To-Head Study Confirms KYPROLIS® (Carfilzomib) Regimen Extends Overall Survival In Patients With Relapsed Multiple Myeloma
Aug 23, 2017
Overall Survival Analysis From KYPROLIS® (carfilzomib) Phase 3 Endeavor Trial Published In The Lancet Oncology
Aug 09, 2017
PharmaMar Starts a Quadruple Combination Study With Aplidin® for the Treatment of Multiple Myeloma
Jul 25, 2017
SkylineDx Researchers Publish Data Demonstrating Utility of SKY92 as Prognostic Tool in Multiple Myeloma (MM)
Jun 20, 2017
Data Presentations at European Hematology Association (EHA) 22nd Annual Congress Further Validate SkylineDx Prognostic Tools in Multiple Myeloma
Jun 19, 2017
FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA® (denosumab) To Include Multiple Myeloma Patients
‹‹
Page 9
››
Latest News
May 15, 2024
VSE Corporation Prices Public Offering of Common Stock
May 15, 2024
Mitsubishi Electric and Musashi Energy Solutions Sign Partnership and Co-Development Contract
May 15, 2024
Owens Corning and Masonite Announce Successful Results of Early Participation in and Amend the Terms of...
May 15, 2024
Poulterra Revolutionizes Poultry Industry with Launch of Innovative Manure-as-a-Service Platform
May 15, 2024
Superior Plus Reports Voting Results of Annual and Special Meeting of Shareholders
May 15, 2024
Superior Plus Declares 2024 Second Quarter Dividend
May 15, 2024
Dynexus’ Rapid EIS Shows Distinct Battery Safety Advantage
May 15, 2024
Tetra Tech Launched Its 2030 Vision at Its Inaugural Investor Day
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events